Short Course Regimen of Doxycycline for the Treatment of Chlamydial Infection
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Participants will take a 3-day course of doxycycline or a 7-day course of doxycycline to
treat urogenital chlamydia infections (women) and rectal infections (men).